FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Lindsey Graham’s final mission nears finish line as world leaders gather to honor him

Democrats target more GOP House seats after socialist victories rock left-wing primaries

Lindsay Clancy’s ex-husband details ‘big spiral’ as expert says one part ‘scared me’ in mom’s murder trial

Heroic 16-year-old lifeguard rescues child from monster surf in heart-stopping video

California family members claim they were attacked at luxury Maui resort during violent melee

Leaked Document Reveals How Senate Republicans Plan to Walk Tightrope on SAVE America Act

19 cadets rushed to hospitals after mystery illness strikes military-style youth academy in DC area

Biden ghostwriter tapes released after former president forfeits legal battle

Biden’s classified docs narrative crumbles amid release of ghostwriter tapes: ‘Be careful’

Trump Calls on John Thune to Hold Senators in D.C. Until They Terminate the Filibuster

Senate advances nomination of Jay Clayton to lead intel community

Georgia teenager pleads guilty to charging Capitol grounds with shotgun

Netflix Executive Takes Legal Action After Being Fired for Workplace Retreat Confession

Senate clears way for Trump’s top spy as key anti-terror program remains in limbo

Summer School: Republicans’ crusade to teach voters the ‘New Math’ on the ‘commie caucus’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”